ACW News 4.96 06/24/2014 04:23:33 Accuride Corporation (ACW)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Accuride Corporation (ACW) 4.96 $ACW

Uptrend Call Working As Accuride Stock Rises 27.2% (ACW)
Comtex SmarTrend(R) - Tue Jun 10, 11:07AM CDT
SmarTrend identified an Uptrend for Accuride (NASDAQ:ACW) on January 7th, 2014 at $4.11. In approximately 5 months, Accuride has returned 27.19% as of today's recent price of $5.22.

Meritor, Inc. (MTOR) in Focus: Stock Jumps 8.4% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Jun 06, 7:37AM CDT
Meritor, Inc. (MTOR) was a big mover last session, as the company saw its shares rise more than 8% on the day.

NYSE stocks posting largest percentage decreases
AP - Tue Jun 03, 5:02PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage decliners on New York Stock Exchange at the close of trading:

29.1% Return Seen to Date on SmarTrend Accuride Call (ACW)
Comtex SmarTrend(R) - Tue Jun 03, 9:41AM CDT
SmarTrend identified an Uptrend for Accuride (NASDAQ:ACW) on January 7th, 2014 at $4.11. In approximately 5 months, Accuride has returned 29.11% as of today's recent price of $5.30.

Photo Release -- Accuride's New Accu-Flange(TM) Aluminum Wheels Fight Flange Wear
GlobeNewswire - Mon Jun 02, 8:33AM CDT
-- Accu-Flange(TM) features a protective surface treatment that reduces rim flange wear

Should Accuride (ACW) Be On Your Radar Now? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri May 30, 7:38AM CDT
Accuride (ACW) looks well positioned for a solid gain, but has been overlooked by investors lately. This Auto Parts stock has actually seen estimates rise over the past month for the current fiscal year by about 53.3%.

Accuride Has Returned 39.6% Since SmarTrend Recommendation (ACW)
Comtex SmarTrend(R) - Tue May 27, 9:09AM CDT
SmarTrend identified an Uptrend for Accuride (NASDAQ:ACW) on January 7th, 2014 at $4.11. In approximately 5 months, Accuride has returned 39.59% as of today's recent price of $5.73.

What Makes Spartan Motors (SPAR) a Strong Sell? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu May 22, 7:45AM CDT
It may be a good decision to sell Spartan Motors's as its price dropped significantly in the past four weeks, the stock witnessed a negative trend in earnings estimate revisions and a Zacks Rank #5 confirms weakness.

Accuride Erie Facility Reaches New Collective Bargaining Agreement
GlobeNewswire - Wed May 21, 3:45PM CDT
-- Agreement lends stability, solidifies competitiveness for the advanced aluminum wheel facility

34.2% Return Seen to Date on SmarTrend Accuride Call (ACW)
Comtex SmarTrend(R) - Mon May 19, 4:42PM CDT
SmarTrend identified an Uptrend for Accuride (NASDAQ:ACW) on January 7th, 2014 at $4.11. In approximately 4 months, Accuride has returned 34.23% as of today's recent price of $5.51.

Strength Seen in SORL Auto Parts (SORL): Stock Soars 20.8% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon May 19, 7:51AM CDT
SORL Auto Parts, Inc. (SORL) was a big mover last session, as the company saw its shares rise nearly 21% on the day.

Accuride to Webcast B. Riley & Co. Conference Presentation
GlobeNewswire - Tue May 13, 8:15AM CDT
Accuride Corporation (NYSE:ACW) - a leading supplier of components to the North American commercial vehicle industry - today announced that it will webcast its investor meeting presentation on Tuesday, May 20, 2014 at the 15th Annual B. Riley & Co. Investor Conference being held at Loews Santa Monica Beach Hotel in Santa Monica, Calif.

Uptrend Call Working As Accuride Stock Rises 35.0% (ACW)
Comtex SmarTrend(R) - Mon May 12, 12:13PM CDT
SmarTrend identified an Uptrend for Accuride (NASDAQ:ACW) on January 7th, 2014 at $4.11. In approximately 4 months, Accuride has returned 34.96% as of today's recent price of $5.54.

Why Accuride Corp. (ACW) Could Be Positioned for a Surge? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon May 12, 7:47AM CDT
Accuride Corp. (ACW), a commercial vehicle components manufacturer, could be an interesting play for investors. That is because, not only does the stock have decent short-term momentum, but it is seeing solid activity on the earnings estimate revision front as well.

Can the Uptrend Continue for Accuride (ACW)? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue May 06, 8:16AM CDT
Can the Uptrend Continue for Accuride (ACW)?

Accuride Shares Up 33.3% Since SmarTrend's Buy Recommendation (ACW)
Comtex SmarTrend(R) - Mon May 05, 9:36AM CDT
SmarTrend identified an Uptrend for Accuride (NASDAQ:ACW) on January 7th, 2014 at $4.11. In approximately 4 months, Accuride has returned 33.25% as of today's recent price of $5.47.

Accuride Corp. (ACW) in Focus: Stock Moves 5.2% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu May 01, 8:18AM CDT
Accuride Corp. (ACW) was a big mover last session, as the company saw its shares rise by over 5% on the day.

Upgrade Alert for Accuride (ACW)
Comtex SmarTrend(R) - Tue Apr 29, 7:56AM CDT
Accuride (NASDAQ:ACW) was upgraded from Fair Value to Buy at CRT Capital today. The stock closed yesterday at $4.97 on volume of 1.2 million shares, above average daily volume of 196,000. Accuride Corp. manufactures and supplies commercial vehicle components in North America. The Company's products include commercial vehicle wheels, wheel-end components and assemblies, truck body and chassis parts, seating assemblies and other commercial vehicle components.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

CARsgen's CT1182 Data Opens a Careful New CAR-T Test

Updated Category News Views 126

Six very sick lymphoma patients are not a victory lap, but they can still make the whole cell-therapy field sit up straighter. CARsgen has disclosed first clinical results for CT1182, an in vivo CAR-T candidate built on its CARvivo platform, and the early package is plainly more interesting than the usual preclinical chest-thumping. The company reported three complete...

Continue Reading
Cardiovalve's Three-Year Data Clears a Crucial EU Hurdle

Updated Category News Views 16

A failing tricuspid valve is not a spreadsheet problem, and that matters before anybody gets carried away with a glossy conference presentation. Venus Medtech's Cardiovalve unit has reported results from TARGET in a population that was old, sick and largely out of good surgical options. That is precisely where a less invasive replacement therapy has to prove it can do...

Continue Reading
Isar’s Nova Scotia Pad Build Gives MAXQ a Real Test

Updated Category News Views 666

Concrete work is where space ambition stops being a brochure. Isar Aerospace has taken operational responsibility for its dedicated launch infrastructure at Spaceport Nova Scotia, and construction is beginning on the Canadian launch pad it will use. For Maritime Launch Services, this is the sort of update that deserves more than the usual starry-eyed applause. A Site...

Continue Reading
Sitting, Lymph Flow, and a Supplement Maker's Pitch

Updated Category News Views 310

By late afternoon, a chair can feel like it has quietly won the argument against your legs. PureHealth Research is leaning into that familiar heavy, puffy-legged feeling with a reminder about lymphatic flow—and, naturally, an eight-ingredient supplement positioned alongside it. The broad message is sensible. The sales layer needs the usual healthy squint. Movement Does...

Continue Reading
Global Child Tests Purpose Travel's Expanding Media Reach

Updated Category News Views 37

Celebrity travel programming usually melts into the wallpaper, but Global Child is trying to make the scenery answer for itself. Its new season of Global Child “Travel & Purpose” puts Andrea Bocelli in Tuscany, Isabela Merced in Peru and John Malkovich in Croatia, while tying each destination to a broader local-good mission. That is a more thoughtful pitch than...

Continue Reading
Human Frontier Mission Puts AI Research on Display

Updated Category News Views 348

A laboratory notebook is about to become the real product in this AI experiment. Human Frontier Mission, or HFM, says it will launch globally on Nov. 24, opening a research program where domain specialists frame scientific and engineering problems while autonomous AI agents develop and test possible answers. The unusual bit is not merely handing models difficult work. It...

Continue Reading
3TREES Tests a Bigger Asia-Pacific Growth Blueprint

Updated Category News Views 386

A bucket of paint rarely sounds strategic until it sits inside a regional supply chain. That is the useful part of 3TREES chairman and president Hong Jie's message from the Asia-Pacific Economic Cooperation CEO Summit in Shenzhen on November 17-18, 2026: coatings are not merely a commodity if the supplier can bring materials, energy savings, technical know-how and...

Continue Reading
Persistent Dry Eye Symptoms Call for a Closer Look

Updated Category News Views 332

Eyes can turn into a stubborn little nuisance long before people realize something more complicated is going on. A bottle of artificial tears is easy to grab, cheap enough, and often perfectly sensible for a rough day of screens, wind, reading, or air conditioning. But Dr. Harlan Snyder’s point is the one worth sitting with: when dryness keeps barging back despite...

Continue Reading
Fractional CIOs Bring Order to Growing Technology Chaos

Updated Category News Views 270

A company can outgrow its technology habits long before anyone notices the smoke. One day the owner is approving another software subscription, the office manager is chasing an internet provider, and the tech person is putting out password fires. None of that looks dramatic in isolation. Together, it is a business operating without a map. That is the useful point in the...

Continue Reading
Lymphatic Research Gains Attention Beyond Wellness Claims

Updated Category News Views 513

Ankles leave little clues after a long day: sock grooves, puffiness, that dull heaviness nobody bothers to name. PureHealth Research wants people to look past the usual salt-and-water explanation and consider the lymphatic system, the body’s comparatively unsung network for gathering fluid from tissues and returning it to the bloodstream. Fair enough. This system does...

Continue Reading

Top 5 Most Recently Viewed Articles

Motorsport Games Achieves Significant Growth in Q3 Results

Updated Category News Views 182

Motorsport Games Shows Promising Financial Trends Motorsport Games Inc. (NASDAQ: MSGM) recently shared its financial outcomes for the third quarter, reflecting remarkable growth. The company, a key player in the racing game industry, recorded significant advancements, particularly highlighted by their flagship title, Le Mans Ultimate. For Q3 2025, Motorsport Games...

Continue Reading
AI Giants Converge in Singapore for SuperAI 2026

Updated Category News Views 52

SuperAI Singapore 2026: A Global Gathering Singapore's Marina Bay Sands is buzzing, folks. With 10,000 people crammed into Asia's largest AI event, SuperAI Singapore 2026 is offering up a melting pot of tech brains from 150 countries. It's sold out like your favorite band’s farewell tour—things kicking off with a big bang. A Melting Pot of Innovation You’ve got...

Continue Reading
Investors' Sentiment Towards Terreno Realty Corp Revealed

Updated Category News Views 128

Understanding Investor Sentiment for Terreno Realty Corp Terreno Realty's short interest has notably surged, reflecting a growing sentiment among investors. Currently, 11.02% increase in short interest reveals that now approximately 6.22 million shares are sold short, making it 10.78% of the float. Observing the trading volume suggests that it would take traders roughly...

Continue Reading
Gilead Sciences Targets Growth Amid Oncology Challenges and Opportunities

Updated Category News Views 208

Gilead Sciences faced significant challenges back in 2024 as its oncology ambitions faltered, all while the company leaned heavily on its HIV stronghold. The stock stumbled, reflecting broader market jitters about its future growth potential. You see, Gilead had been riding high on Biktarvy, a blockbuster that held nearly 49% of the U.S. HIV treatment market. Analysts...

Continue Reading
Captify Launches Innovative Election War Room Insights 2024

Updated Category News Views 124

Captify Launches the Election War Room for the 2024 Elections Captify, a leader in real-time audience analytics powered by Search Intelligence, has introduced the Captify Election War Room—a weekly data report that spotlights what people are searching for during the 2024 U.S. election cycle. As the race intensifies, brands and campaign teams want a clearer view of how...

Continue Reading